|
65
|
211
|
5l5vK |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
66
|
250
|
5l66A |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
63
|
222
|
5lajL |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
76
|
248
|
5lf6B |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
69
|
243
|
5lajF |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
64
|
200
|
5lf0K |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
67
|
242
|
5lajD |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
70
|
212
|
5bxlK |
Yeast 20s proteasome beta2-g170a mutant |
|
67
|
233
|
5l5jM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
62
|
222
|
5l61L |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
62
|
211
|
5l5zK |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
65
|
240
|
5l5iC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
71
|
243
|
5l5wF |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
64
|
233
|
5le5D |
Native human 20s proteasome at 1.8 angstrom |
|
61
|
233
|
5lf6D |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
68
|
240
|
5l5uC |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
67
|
244
|
5lajB |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
62
|
233
|
5lf0D |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
69
|
250
|
5l5rA |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
67
|
250
|
5l65A |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
65
|
240
|
5lajC |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
64
|
237
|
5lf6C |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
59
|
196
|
5laiN |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
68
|
239
|
5lf3F |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
56
|
195
|
5l5yJ |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
60
|
196
|
5l6aN |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
68
|
242
|
5l5bD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
|
55
|
204
|
5lexI |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
59
|
195
|
5l5tJ |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
59
|
226
|
5l67H |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
71
|
240
|
5laiC |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
64
|
241
|
5lajG |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
56
|
204
|
5l5aI |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
67
|
240
|
5l5fC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
58
|
204
|
5l64I |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
59
|
204
|
5laiI |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
61
|
195
|
5lajJ |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
60
|
222
|
5l5pL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
58
|
204
|
5l60I |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
55
|
204
|
5leyI |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
62
|
211
|
5l5jK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
64
|
211
|
5m2bK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
60
|
234
|
5lf6E |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
67
|
250
|
5l55A |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
69
|
242
|
5l5tD |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
69
|
240
|
5l66C |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
62
|
233
|
5lf1D |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
59
|
222
|
5l5rL |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
71
|
243
|
5l63F |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
69
|
250
|
5laiA |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
